Sound Pharmaceuticals, Incorporated

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Sound Pharmaceuticals, Incorporated sits in the top decile of US sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count).

9 total trials 2 currently recruiting 7 completed early-phase tilt top decile by trial count

Sound Pharmaceuticals, Incorporated: 9 sponsored US clinical trials, 2 recruiting.

Sound Pharmaceuticals, Incorporated sponsors 9 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 7 completed. 2 of these trials are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cochlear Trauma, with 1 trials.

Top-decile sponsor footprint

Sound Pharmaceuticals, Incorporated ranks in the top decile of sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

9 total, page 1 of 1

RECRUITING Phase 3

SPI-1005 for the Treatment of Meniere's Disease (Open Label)

NCT06859788
RECRUITING Phase 2

SPI-1005 in Adults Receiving Cochlear Implant

NCT06340633
COMPLETED Phase 3

SPI-1005 for the Treatment of Meniere's Disease

NCT04677972
COMPLETED Phase 2

SPI-1005 Treatment in Severe COVID-19 Patients

NCT04483973
COMPLETED Phase 2

SPI-1005 for the Treatment of Patients With Meniere's Disease

NCT03325790
COMPLETED Phase 2

SPI-1005 for Prevention and Treatment of Tobramycin Induced Ototoxicity

NCT02819856
COMPLETED Phase 1

Study to Evaluate SPI-1005 in Adults With Meniere's Disease

NCT02603081
COMPLETED Phase 2

Otoprotection With SPI-1005 for Prevention of Temporary Auditory Threshold Shift

NCT01444846
COMPLETED Phase 1

Study to Evaluate the Safety and Pharmacokinetics of SPI-1005

NCT01452607

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 2 5
Phase 3 2

Therapeutic Areas

Cochlear Trauma 1
Ménière's Disease 1
Ménière 1
Meniere Disease 1
Meniere's Disease 1
Hearing Loss 1

What is open in the Sound Pharmaceuticals, Incorporated pipeline

2 recruiting of 9 indexed (22% open); 7 completed (78%).

Phase mix: 2 late (III/IV) vs 7 early (I/II) (early-phase heavy).

Top condition: Cochlear Trauma (1 trial), 5 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Sound Pharmaceuticals, Incorporated: open-pipeline peers nationwide

Peers matched on 9 registered trials and 22% open enrollment, not the therapeutic-area sidebar.

Sound Pharmaceuticals, Incorporated sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 8101214161820 0%10%20%30%40%50% Total trials Recruiting share Sound Pharmaceuticals, Incorporated4D Molecular Therapeutics9 Meters BiopharmaAadi BioscienceAblynx, a Sanofi companyALX OncologyBiosense WebsterEnglewood Hospital and Medical CenterEnsysce Biosciences
Sound Pharmaceuticals, Incorporated sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Sound Pharmaceuticals, Incorporated sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 9 trials (± recruiting share)

Sponsors near 22% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Sound Pharmaceuticals, Incorporated page

9 registered trials is a research-attention snapshot, not an endorsement of Sound Pharmaceuticals, Incorporated or any single study.

  • 2 of Sound Pharmaceuticals, Incorporated's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Cochlear Trauma is the condition Sound Pharmaceuticals, Incorporated studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cochlear Trauma trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Sound Pharmaceuticals, Incorporated pipeline card: 9 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.